Clinical research in København S is advancing acute cardiac care by evaluating early therapeutic interventions for heart attacks and their effects on heart function. Immediate versus delayed beta blocker administration after STEMI Role of ACE inhibitor therapy in post‑infarct remodeling Impact of SGLT2 inhibitor treatment on cardiac biomarkers Assessment of echocardiographic parameters in acute myocardial infarction These studies aim to refine emergency protocols and improve long‑term outcomes for patients with cardiovascular emergencies.

Neoplasms

A diverse portfolio of oncology trials in København S targets melanoma, breast, pancreatic and other solid tumours, exploring immunotherapy, targeted radioligand therapy and cellular approaches. Neoadjuvant pembrolizumab for stage IIb/c melanoma Conversion of triple‑negative breast cancer to ER‑positive disease Combination of 177Lu‑DOTA‑TATE with olaparib for somatostatin receptor‑positive tumours Autologous tumor‑infiltrating lymphocytes infusion for melanoma with liver metastases The overarching goal is to personalize treatment, increase response rates, and expand therapeutic options for patients with aggressive cancers.

Nervous System Diseases

Ongoing investigations in København S focus on multiple sclerosis, comparing CD20‑targeted antibodies and exploring dosing strategies to sustain disease control. Non‑inferiority comparison of rituximab versus ocrelizumab in active MS Extended‑interval dosing of CD20‑depleting agents MRI‑based monitoring of new or enlarging T2 lesions Long‑term safety evaluation over five years Findings aim to optimize therapeutic regimens and improve quality of life for individuals living with neuro‑inflammatory disease.

Stomatognathic Diseases

Research on temporomandibular joint disorders in København S compares minimally invasive techniques to reduce pain and restore jaw function. Efficacy of intra‑articular corticosteroid injection for TMJ arthritis Pain relief comparison with arthrocentesis Functional outcome assessment of mandibular mobility Patient‑reported quality of life after TMJ interventions The trials seek to establish evidence‑based guidelines for managing TMJ pain and improving oral health outcomes.

Mental Disorders

A pilot study in København S examines metabolic side effects of antipsychotic treatment in youth, testing a GLP‑1 receptor agonist as an adjunct therapy. Feasibility of GLP‑1 receptor agonist treatment in antipsychotic‑treated adolescents Effect on body weight and metabolic parameters Integration with standard psychiatric care pathways Safety and tolerability in the pediatric population Results could provide a novel strategy to mitigate obesity while preserving mental health benefits.

Back to Denmark All countries

Clinical trials in København S

8 trials in København S

Obesity

Study of semaglutide treatment for adolescents with obesity caused by antipsychotic medications

Osteoarthritis

Study Comparing Corticosteroid Injection and Arthrocentesis for Temporomandibular Joint Arthritis in Patients Using Methylprednisolone Acetate and Lidocaine Hydrochloride

Pancreatic carcinoma

Study on the Effects of Histamine Dihydrochloride and Aldesleukin in Patients with Resectable Pancreatic Cancer

Acute myocardial infarction

Study on the Effects of Ramipril, Bisoprolol, and Dapagliflozin in Patients with ST-Elevation Myocardial Infarction (Heart Attack)

Triple negative breast cancer

Study on Imatinib for Patients with Triple Negative Breast Cancer to Convert it to ER-Positive Breast Cancer

Malignant melanoma stage II

Study of Pembrolizumab for Patients with Stage IIb/c Melanoma

Relapsing-remitting multiple sclerosis+2

Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

Post procedural complication

Study on Argipressin and Sodium Chloride to Reduce Blood Loss in Liver Surgery for Patients with Liver Cancer or Tumors

Filter the trials

Other cities in Denmark

Clinical research in København S

Prefer not to search? Our Concierge searches the trials for you.